Imed Infinity Medical-Limited Partnership Past Earnings Performance
Past criteria checks 0/6
Imed Infinity Medical-Limited Partnership's earnings have been declining at an average annual rate of -32.1%, while the Medical Equipment industry saw earnings growing at 8.4% annually. Revenues have been declining at an average rate of 34.9% per year.
Key information
-32.1%
Earnings growth rate
6.6%
EPS growth rate
| Medical Equipment Industry Growth | 15.2% |
| Revenue growth rate | -34.9% |
| Return on equity | -15.4% |
| Net Margin | 238.8% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Imed Infinity Medical-Limited Partnership makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 0 | -1 | 1 | 0 |
| 31 Mar 24 | -1 | -1 | 1 | 0 |
| 31 Dec 23 | -1 | -2 | 1 | 0 |
| 30 Sep 23 | -1 | -2 | 1 | 0 |
| 30 Jun 23 | 0 | -1 | 1 | 0 |
| 31 Mar 23 | 0 | -1 | 1 | 0 |
| 31 Dec 22 | 0 | -1 | 1 | 0 |
| 30 Sep 22 | 0 | -1 | 1 | 0 |
| 30 Jun 22 | 0 | -1 | 1 | 0 |
| 31 Mar 22 | 0 | -1 | 1 | 0 |
| 31 Dec 21 | 0 | -1 | 1 | 0 |
Quality Earnings: IMED is currently unprofitable.
Growing Profit Margin: IMED is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IMED is unprofitable, and losses have increased over the past 5 years at a rate of 32.1% per year.
Accelerating Growth: Unable to compare IMED's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IMED is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-2.4%).
Return on Equity
High ROE: IMED has a negative Return on Equity (-15.44%), as it is currently unprofitable.